An investigation on behalf of investors in NASDAQ:SKLN shares over potential wrongdoing at Skyline Medical Inc was announced and NASDAQ:SKLN stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 08/11/2017 -- An investigation on behalf of investors in shares of Skyline Medical Inc (NASDAQ:SKLN) was announced over potential breaches of fiduciary duties by certain directors.
Investors who purchased shares of Skyline Medical Inc (NASDAQ:SKLN) and currently hold any of those NASDAQ:SKLN shares have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call 858-779-1554.
The investigation by a law firm concerns whether certain Skyline Medical directors breached their fiduciary duties and caused damage to the company and its shareholders.
Skyline Medical Inc. is a medical device company that develops and manufactures The STREAMWAY System, a solution for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. Shares of Skyline Medical Inc (NASDAQ:SKLN) declined from $4.74 per share in November 2016 to as low as $1.31 per share in June 2017.
On August 10, 2017, NASDAQ:SKLN shares closed at $1.50 per share.
Those who purchased shares of Skyline Medical Inc (NASDAQ:SKLN), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego